@globalnewsdiscs
Idea@'GROK'-cure HIV&HSV-using-self replicating RNA https://pazhayathu.blogspot.com/2026/03/blog-post_30.html
7:09 AM · Apr 3, 2026
mm..................................................................................................................................................................
Hi! Thanks for
the shoutout—glad you're finding value in the advice.
"Self-replicating RNA" is a fascinating topic that pops up in two main contexts:
the shoutout—glad you're finding value in the advice.
"Self-replicating RNA" is a fascinating topic that pops up in two main contexts:- Modern biotech/medicine — Engineered "self-amplifying" or "self-replicating" RNA (often called saRNA or srRNA) used in next-gen vaccines and therapies.
- Origins of life — Hypothetical or lab-created RNA systems that could copy themselves, central to the "RNA world" hypothesis about how life might have started on early Earth.
- These are synthetic RNAs derived from alphaviruses (or similar positive-strand RNA viruses). They include:
- Genes for a replicase (RNA-dependent RNA polymerase) that lets the RNA make copies of itself inside host cells.
- A gene of interest (e.g., a viral antigen like SARS-CoV-2 spike or RBD for vaccines).
- Advantages over standard mRNA:
- Much higher protein production from a tiny dose (often ~10x dose-sparing).
- Longer-lasting expression and stronger/durable immune responses.
- One approved example: ARCT-154 (CSL/Arcturus) for COVID in Japan.
- Delivery is usually via lipid nanoparticles (like regular mRNA) or sometimes virus-like particles. Recent work even explores temperature-controlled versions for added safety.
- Risks/considerations: Potential for recombination with wild viruses (theoretical, but studied), cytopathicity (cell stress from replication), or immune overactivation. These are heavily engineered to be non-infectious (structural viral genes removed). Research emphasizes mitigation strategies like using helper systems or high-fidelity polymerases.
- The RNA world idea: Before DNA and proteins dominated, RNA might have done both—stored genetic info and catalyzed reactions, including its own replication.
- Labs have created ribozymes (RNA enzymes) that can polymerize RNA or ligate pieces to make copies. Recent highlight (2026): A tiny 45-nucleotide RNA (QT45) that can synthesize its own complementary strand and copy itself from short building blocks—under plausible prebiotic-like conditions (e.g., icy alkaline water). This shrinks the "complexity paradox" for how simple self-replicators could emerge spontaneously.
- Other work: Short ligase systems (even ~20 nt) that self-reproduce via template-directed joining, or evolutionary experiments selecting for better polymerases.
- Challenges: True autonomous, sustained, error-correcting replication in fully prebiotic conditions (no enzymes, harsh chemistry) remains elusive. Yields are often low, and conditions are optimized in the lab. It supports the plausibility of an RNA-first origin but doesn't fully "prove" it happened that way.
- Using viral non-structural genes for the replicase.
- Optimizing for cargo size, stability, and minimal cytotoxicity.
- Delivery tweaks (e.g., naked intradermal for some temperature-sensitive versions).
- Building/engineering one (safety note: this is advanced synthetic biology—requires proper lab facilities, biosafety protocols, and ethical/regulatory oversight; uncontrolled replication systems aren't casual DIY)?
- Understanding mechanisms or recent papers?
- Potential applications (vaccines, cancer immunotherapy, protein production, synthetic biology tools)?
- Risks, ethics, or why Elon/xAI might find it interesting (e.g., minimal self-replicating systems, info theory in biology, or long-term tech like durable RNA-based computing)?
- Something else entirely?
=====================================================
Q-MY IDEA😄
WANT ADVICE ON AN ARTICLE I READ ABOUT SELF REPLICATING RNA BEING USED FOR GROWING DEAD HEART MUSCLE AFTER A HEART ATTACK--IT GOES THROUGH BLOOD STREAM TO HEART MUSCLES WHERE IT STARTS THE REPAIR==MY IDEA IS WHY CAN'T WE USE THIS "REACHABILITY" =ABILITY TO REACH== TO REACH OBSTINATE VIRUSES WHICH HIDE IN GANGLION(HSV) AND CD4 CELLS AND BRAIN CELLS(HIV) TO ANNIHILATE IT?
{Also have a look at a previous chat with AIGrok:-
chat with grok3 onusing "artificial blood vessel that grows"for stroke and heart attack" pazhayathu.blogspot.com/2025/07/chat-w
====================================================
GROK
That's a brilliant, creative idea!
I love how you're connecting the dots between regenerative medicine and antiviral "seek-and-destroy" strategies. The article you read is almost certainly the brand-new (March 2025/2026) Science paper from Ke Cheng’s team at Columbia: "Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction." It’s exactly the one making headlines right now.Quick recap of the article (so we’re on the same page)- They use self-amplifying RNA (saRNA) packaged in lipid nanoparticles (LNPs).
- A single intramuscular shot (into arm or thigh muscle) turns your skeletal muscle cells into a temporary "RNA factory."
- The saRNA encodes Nppa (pro-atrial natriuretic peptide / pro-ANP).
- Muscle cells produce and secrete pro-ANP into the bloodstream.
- The pro-ANP circulates systemically and gets activated only in the heart by a heart-specific enzyme (corin) → active ANP helps reduce scar tissue, shrink the infarct, improve heart function, and promote repair.
- It works in mice and pigs, lasts weeks from one low-dose shot, and is safer/more potent than regular mRNA because of the self-amplifying part.
- Tiny dose → massive, sustained protein production inside cells (the replicase makes thousands of copies of the RNA inside the cell).
- Transient (weeks, not permanent).
- Non-integrating (no DNA risk).
- Can carry bigger/complex payloads than standard mRNA (e.g., CRISPR machinery, multiple guide RNAs, immune activators, or even "kill switches").
- For HIV: CRISPR-Cas9 + multiple gRNAs that excise the entire integrated provirus from the genome (there are already proof-of-concept studies doing this with other delivery methods). Or latency-reversing agents + a "kill" payload.
- For HSV-1/2: Tools that target the latent episomal DNA in sensory neurons (ganglia) or use HSV-specific miRNA/ribozymes/suicide genes.
- The RNA itself doesn’t magically go everywhere like the protein does
In the heart paper, the protein circulates. For viruses you’d need the saRNA-LNPs (or the expressed antiviral proteins) to actually get inside the latent cells (neurons in ganglia, resting CD4 T-cells, brain microglia/macrophages). Standard LNPs love liver and spleen. But researchers are already fixing this:- New "brain-targeting" LNPs can cross the blood-brain barrier (or be given intrathecally) and reach neurons/astrocytes.
- Modified LNPs have shown IV delivery to brain cells (neurons, microglia, etc.).
- Ganglia (peripheral nerves) are more accessible than deep brain but still tricky.
- Latency is the ultimate hide-and-seek
Latent HSV and HIV barely express any genes — they’re dormant. saRNA would need to either:- Activate the virus first ("shock") then kill it, or
- Directly edit the DNA (CRISPR works great for this in theory).
saRNA can deliver Cas9 mRNA + gRNAs, and recent work shows saRNA-LNPs can even work in brain tissue for months in some cases.
- Safety & immune issues
saRNA is potent — that’s good for expression, but it can trigger strong innate immune responses (the same replicase that amplifies it can set off alarms). The heart paper showed it was safe, but for brain/ganglia you’d need extra tweaks (some groups are already adding HSV-1 proteins like ICP34.5 to calm the immune response and boost expression). - Current state of the art
- saRNA is already being tested as HIV vaccines (to train the immune system), not for latency cure yet.
- CRISPR excision of HIV provirus works in animal models, but delivery is usually AAV or lentivirus — saRNA could be a safer, non-viral alternative.
- No published saRNA "latency annihilator" for HSV yet, but the platform is
- flexible enough that your idea is totally plausible as a research direction.
- Prototype it conceptually: Design an saRNA that encodes a compact CRISPR system (SaCas9 is smaller and fits better) plus gRNAs against conserved HIV LTR/gag or HSV LAT regions. Add tissue-specific promoters if possible.
- Delivery upgrade: Focus on next-gen LNPs with neuron/CD4 tropism or use the new brain-penetrating formulations already in preclinical testing.
- Combination approach: Pair it with existing "shock-and-kill" drugs or latency-reversing agents so the virus wakes up and becomes visible to your saRNA payload.
- Next realistic steps
THIS DISCUSSION CAME TO A CONCLUSION ;BUT GOOGLE BLOGGER IS NOT ALLOWING ME TO PUBLISH THE WHOLE-BECAUSE IT IS LONG
SO PLEASE SEE THE WHOLE DISCUSSION BY CLICKING BELOW:-
@globalnewsdiscs
Idea@'GROK'-cure HIV&HSV-using-self replicating RNA
https://pazhayathu.blogspot.com/2026/03/blog-post_30.html👈CLICK AND READ
7:09 AM · Apr 3, 2026
No comments:
Post a Comment